"TH to issue results ... not sure if that is a good sign or a bad sign given it is an open label trial and results were touched on previously"
I know details aren't your strong point, but the primary endpoints for this trial are:
- Incidence of changes from baseline in haematology, biochemistry, and urinalysis parameters. [Time Frame: 24 weeks]
- Incidence and severity of treatment-emergent adverse events (TEAEs) [Time Frame: 24 weeks]
Results for these outcomes have not been released yet for any patients. So results have not been "touched on" previously.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 16.0¢ | $1.021K | 6.379K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 287922 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 11129 | 4 |
View Market Depth
| Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |